Browse site A to Z

Search results

Search Type: Criteria:

Description: Date Time Location Chair Agenda Council of Governors 24/07/2024 14:00 - 16:00 Conference Room, Heartbeat/Microsoft Teams Jenni
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Governors/Papers-CoG-24.07.2024.pdf

Description: Workforce Race Equality Standard Annual Report 2023 1 Table of Contents Executive Summary................................................................................................................................. 3 Introduction ............................................................................................................................................ 5 WRES Data Submission 2023 .................................................................................................................. 5
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Equality-reports/WRES-report-and-action-plan-2023.pdf

Description: Chemotherapy Protocol Chronic Myeloid Leukaemia Asciminib Regimen • Asciminib Indication • Patients with chronic phase Philadelphia chromosome-positive chronic myeloid Leukaemia previously treated
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/Asciminib.pdf

Description: ANNUAL REPORT AND ACCOUNTS 2019/20 Incorporating the quality account 2019/20 Page 2 University Hospital Southampton NHS Foundation Trust Annual
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Annual-reports-and-quality-accounts/annual-report-and-quality-account-2019-202.pdf

Description: Workforce Race Equality Standard - Annual Report 2022 Table of Contents Executive Summary 3 Introduction 5 WRES Data Submission 2022 6 Indicato
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Equality-reports/Workforce-Race-Equality-Standard-Annual-Report-2022.docx

Description: Chemotherapy Protocol Chronic Myeloid Leukaemia Nilotinib (chronic phase) Regimen • CML – Nilotinib (chronic phase) Indication • As an option for the treatment of
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/NilotinibChronic.pdf

Description: Chemotherapy Protocol Chronic Myeloid Leukaemia Nilotinib (accelerated phase) Regimen • CML – Nilotinib (accelerated phase) Indication • Nilotinib is an option for the treatment
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/NilotinibAccelerated.pdf

Description: Regimen Chemotherapy Protocol BREAST CANCER EVEROLIMUS and EXEMESTANE • Breast Cancer – Everolimus-Exemestane Indication • The first or second line treatment of post
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Everolimus-Exemestane.pdf

Description: Guidance for new UHS* grant holders Congratulations, you’ve been awarded some research funding! Now what? What a
Url: /Media/Southampton-Clinical-Research/Grants/Download/Guidance-for-new-grant-holders-FINAL-Oct2019.pdf

Description: A leading doctor based at Southampton's university hospitals has warned against the use of home genetic testing kits and called for
Url: /AboutTheTrust/Newsandpublications/Latestnews/2019/October/Press-release-Southampton-expert-says-home-genetic-testing-kits-shouldnt-be-used-for-healthcare-decisions.aspx

51 to 60 of 479

Previous … 4 5 6 7 8 … Next